Logo

Perlegen Wins $2.1M NIDA Grant to Study Genetics of Nicotine Addiction

Nov 17, 2004

NEW YORK, Nov. 17 (GenomeWeb News) - Perlegen Sciences has received a $2.1 million contract from the US National Institute on Drug Abuse to study genetic variations and candidate genes associated with nicotine addiction, the firm said today.

 

Scientists at WashingtonUniversity in St. Louis will use Perlegen technology to analyze more than 1.5 million SNPs across the genome in people highly addicted to nicotine. They will compare their findings with those conducted on people who are not addicted to nicotine.

Breaking News
The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.